184 related articles for article (PubMed ID: 34838461)
1. Localized Well-Differentiated Rectal Neuroendocrine Tumors - Where Are We in 2021?
Amorim LC; Ferreira AR; Perez RO; Peixoto RD
Clin Colorectal Cancer; 2022 Mar; 21(1):e22-e27. PubMed ID: 34838461
[TBL] [Abstract][Full Text] [Related]
2. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.
Anthony LB; Strosberg JR; Klimstra DS; Maples WJ; O'Dorisio TM; Warner RR; Wiseman GA; Benson AB; Pommier RF;
Pancreas; 2010 Aug; 39(6):767-74. PubMed ID: 20664474
[TBL] [Abstract][Full Text] [Related]
3. [Progress in diagnosis and treatment of rectal neuroendocrine neoplasms].
Wu ZJ; Zhou MY; Zheng ZX; Bi JJ; Wang XS; Feng Q
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):438-444. PubMed ID: 32575937
[TBL] [Abstract][Full Text] [Related]
4. Rectal NETs and rectosigmoid junction NETs may need to be treated differently.
Cai W; Ge W; Hu H; Mao J
Cancer Med; 2020 Feb; 9(3):971-979. PubMed ID: 31840409
[TBL] [Abstract][Full Text] [Related]
5. Multiple rectal neuroendocrine tumors: report of five cases.
Park CS; Lee SH; Kim SB; Kim KO; Jang BI
Korean J Gastroenterol; 2014 Aug; 64(2):103-9. PubMed ID: 25168053
[TBL] [Abstract][Full Text] [Related]
6. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection.
Chung HG; Goh MJ; Kim ER; Hong SN; Kim TJ; Chang DK; Kim YH
J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790
[TBL] [Abstract][Full Text] [Related]
7. The incidence, treatment and survival of patients with rare types of rectal malignancies in the Netherlands: A population-based study between 1989 and 2018.
van Rees JM; Elferink MAG; Tanis PJ; de Wilt JHW; Burger JWA; Verhoef C
Eur J Cancer; 2021 Jul; 152():183-192. PubMed ID: 34118528
[TBL] [Abstract][Full Text] [Related]
8. Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
Cope J; Srirajaskanthan R
Curr Oncol Rep; 2022 Mar; 24(3):257-263. PubMed ID: 35084662
[TBL] [Abstract][Full Text] [Related]
9. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
[TBL] [Abstract][Full Text] [Related]
10. Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility.
Fu Z; Zuo C; Sheehan CE; Patil DT; Lin J; Yang Z; Lee H
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):454-460. PubMed ID: 29561272
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.
Niederle MB; Niederle B
Oncologist; 2011; 16(5):602-13. PubMed ID: 21467149
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
[TBL] [Abstract][Full Text] [Related]
13. [Rectal neuroendocrine tumours].
Louthan O
Klin Onkol; 2009; 22(5):195-201. PubMed ID: 19886356
[TBL] [Abstract][Full Text] [Related]
14. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract][Full Text] [Related]
15. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of rectal multiple neuroendocrine neoplasms and literature review.
Zheng X; Wu M; Li S; Er L; Deng H; Guo S; Liu Z
BMC Surg; 2023 Jun; 23(1):147. PubMed ID: 37264328
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic study of the rectum in 1,464 consecutive rectal specimens in a single Japanese hospital: II. malignant lesions.
Terada T
Int J Clin Exp Pathol; 2013; 6(3):385-94. PubMed ID: 23412998
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
[TBL] [Abstract][Full Text] [Related]
19. [Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: good prognosis with early detection].
Scherübl H; Faiss S; Jahn HU; Liehr RM; Schwertner C; Steinberg J; Stölzel U; Weinke T; Zimmer T; Klöppel G
Dtsch Med Wochenschr; 2009 Jul; 134(30):1529-35. PubMed ID: 19603370
[TBL] [Abstract][Full Text] [Related]
20. Low-grade Rectal Neuroendocrine Tumor Recurring as Multiple Hepatic Metastasis after Complete Endoscopic Removal: A Case Report.
Jo IH; Lee KM; Kim DB; Lee JM
Korean J Gastroenterol; 2020 Nov; 76(5):251-255. PubMed ID: 33234773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
